scholarly journals Resection and adjuvant chemotherapy of pulmonary blastoma: A case report

Cancer ◽  
1996 ◽  
Vol 78 (3) ◽  
pp. 569-569
Author(s):  
Henrik Larsen ◽  
Jens Benn Sørensen
Keyword(s):  
Case Report ◽  
Adjuvant Chemotherapy ◽  
Pulmonary Blastoma

scholarly journals Resection and adjuvant chemotherapy of pulmonary blastoma: A case report

Cancer ◽  
1996 ◽  
Vol 78 (3) ◽  
pp. 569-570 ◽  
Author(s):  
Juan A. López-Andreu ◽  
Josep Ferrís ◽  
Isidoro Cortell ◽  
José M. Roqués
Keyword(s):  
Case Report ◽  
Adjuvant Chemotherapy ◽  
Pulmonary Blastoma

A RECURRENCE BIPHASIC PULMONARY BLASTOMA AFTER ADJUVANT CHEMOTHERAPY : A CASE REPORT OF RARE LUNG MALIGNANCY

2017 ◽  
pp. 1
Author(s):  
Asmaa Lakhdissi ◽  
Ibrahim Elghissassi ◽  
Khadija Bellahammou ◽  
Salif Balde ◽  
Sarra Akla ◽  
...  
Keyword(s):  
Case Report ◽  
Adjuvant Chemotherapy ◽  
Pulmonary Blastoma ◽  
Lung Malignancy

Pulmonary blastoma in a 13-year-old boy. Case report and review of the literature

1984 ◽  
Vol 1 (1) ◽  
pp. 147-155 ◽  
Author(s):  
An Békássy ◽  
S Garwicz ◽  
H Henrikson ◽  
I Hägerstrand ◽  
T Wiebe
Keyword(s):  
Case Report ◽  
Pulmonary Blastoma ◽  
Review Of The Literature

scholarly journals Sigmoid Carcinoma in an Inguinal Hernia: A Blessing in Disguise?

2013 ◽  
Vol 2013 ◽  
pp. 1-3
Author(s):  
P. B. Salemans ◽  
G. F. Vles ◽  
S. A. F. Fransen ◽  
R. M. Smeenk
Keyword(s):  
Colorectal Cancer ◽  
Case Report ◽  
Inguinal Hernia ◽  
Adjuvant Chemotherapy ◽  
Sigmoid Resection ◽  
Oncological Resection ◽  
Sigmoid Carcinoma

Colorectal cancer is a rising problem, as the incidence increases with age. In most cases the goal of treatment is oncological resection followed by adjuvant chemotherapy in order to optimize the survival. In this case report we present a 93-year-old patient with a sigmoid carcinoma inside an irreducible inguinal hernia, which was diagnosed prior to surgery. We chose to perform a sigmoid resection through an oblique inguinal incision as a safer alternative to laparotomy.

scholarly journals Primary Osteosarcoma of the Breast: A Case Report

2013 ◽  
Vol 2013 ◽  
pp. 1-3 ◽  
Author(s):  
Anna Rizzi ◽  
Alberto Soregaroli ◽  
Claudia Zambelli ◽  
Fausto Zorzi ◽  
Stefano Mutti ◽  
...  
Keyword(s):  
Case Report ◽  
Adjuvant Chemotherapy ◽  
Soft Tissue ◽  
Clinical Features ◽  
Optimal Treatment ◽  
Skeletal System ◽  
Case Presentation ◽  
Primary Osteosarcoma ◽  
Haematogenous Spread ◽  
Tissue Form

Introduction. Primary osteosarcoma of the breast is a rare soft-tissue form of osteosarcoma without involvement of the skeletal system. Due to the rarity of the disease, its clinical features and optimal treatment remain unclear.Case Presentation. This case report deals with a 62-year-old woman with pure osteosarcoma of the breast.Conclusions. The prognosis of primary osteosarcoma of the breast is poor. Recurrence is frequent, and it is often associated with haematogenous spread of the disease to the lung. Treatment follows the model of sarcomas affecting other locations and must be planned in a multidisciplinary fashion. Adjuvant chemotherapy should be considered for patients with tumors showing aggressive features.

scholarly journals A Case Report of Primary Pulmonary Choriocarcinoma in a Man: Successful Combination of Surgery and Chemotherapy

2020 ◽  
Vol 13 (2) ◽  
pp. 923-928
Author(s):  
Hang Thi Thuy Nguyen ◽  
Hung Huy Hoang ◽  
Anh Thi Van Le
Keyword(s):  
Case Report ◽  
Adjuvant Chemotherapy ◽  
Malignant Tumor ◽  
Rare Case ◽  
Rare Condition ◽  
Optimal Treatment ◽  
Reproductive Age ◽  
Women Of Reproductive Age ◽  
Standardized Treatment

Choriocarcinoma is a malignant tumor that typically appears in gonadal organs and primarily occurs in women of reproductive age. Being a primary extragonadal choriocarcinoma, primary pulmonary choriocarcinoma (PPC) is an extremely rare condition. Due to the rarity of PPC, no standardized treatment has been established so far. However, surgery combined with adjuvant chemotherapy appears to be the most optimal treatment. Here, we report a rare case of a man with PPC that was successfully treated with surgery followed by chemotherapy.

Pegfilgrastim-associated large-vessel vasculitis developed during adjuvant chemotherapy for breast cancer: A case report and review of the literature

2020 ◽  
Vol 26 (7) ◽  
pp. 1785-1790 ◽  
Author(s):  
Jun Nakamura ◽  
Tomoyo M Nishi ◽  
Shun Yamashita ◽  
Hiroaki Nakamura ◽  
Ken Sato ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Case Report ◽  
Adjuvant Chemotherapy ◽  
Supportive Therapy ◽  
Granulocyte Colony Stimulating Factor ◽  
Review Of The Literature ◽  
Breast Cancer Chemotherapy ◽  
Prophylactic Use ◽  
Stimulating Factor ◽  
Rule Out

Introduction Granulocyte colony-stimulating factor (G-CSF) is widely used as a neutrophil supportive therapy in breast cancer chemotherapy. Common adverse events of G-CSF include bone pain, headache, and fatigue; however, reports of G-CSF-associated vasculitis are few. Case report A 66-year-old woman who had undergone surgery for breast cancer received adjuvant chemotherapy with prophylactic use of pegfilgrastim (peg-G). She developed peg-G-associated vasculitis 11 days after initially receiving peg-G. Management and outcome: Although various blood and culture tests were required to rule out other vasculitis syndromes and infections, her symptoms spontaneously disappeared without any treatment other than discontinuation of the causal drug. Discussion G-CSF-associated vasculitis is occasionally accompanied by severe complications such as aortic dissection and aneurysm formation. This case report is important to draw attention towards this rare and difficult-to-diagnosis adverse event of peg-G.

Sign in / Sign up

Export Citation Format

Share Document